(Q39471341)

12 September 2017

Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting (English)

1 reference

12 September 2017

0 references

1 reference

1

Liam Smeeth

1 reference

12 September 2017

6

Patrick Vallance

1 reference

12 September 2017

Claire Cook

2

1 reference

12 September 2017

Sara Thomas

series ordinal

3

1 reference

12 September 2017

Andrew J Hall

series ordinal

4

1 reference

12 September 2017

Richard Hubbard

series ordinal

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

12 September 2017

1 reference

12 September 2017

367

1 reference

12 September 2017

1075-1079

1 reference

12 September 2017

9516

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

12 September 2017

1 reference

7 January 2021

Incidence of diagnosed deep vein thrombosis in the general population: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Acute respiratory-tract infections and risk of first-time acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Risk of myocardial infarction and stroke after acute infection or vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Relative incidence estimation from case series for vaccine safety evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Control without separate controls: evaluation of vaccine safety using case-only methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Validation of the diagnosis of venous thromboembolism in general practice database studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

Open randomised trial of prescribing strategies in managing sore throat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968474-2

7 January 2021

10.1016/S0140-6736(06)68474-2

Identifiers

DOI

1 reference

12 September 2017

1 reference